Abstract
Malignant Mesothelioma: Asbestos are naturally occurring fibrous silicate materials. It is well recognised that inhalation of asbestos fibres especially amphiboles is the most important risk factor for developing mesothelioma. The epidemiological models of association between the risks of asbestos and malignant mesothelioma take into consideration not only cumulative exposure but also time since first exposure. Current epidemiological estimates suggest that mesothelioma will remain a public health problem for a number of years with epidemiological studies suggesting that the peak incidence of mesothelioma has not been reached. In the global context, mesothelioma remains responsible for between 15,000 - 20,000 deaths annually. Malignant mesothelioma can be divided as per World Health Organization classification into epithelioid, sarcomatoid, desmoplastic and biphasic subtypes.
Keywords: Asbestos, epidemiology, malignant mesothelioma, pathology.
Current Respiratory Medicine Reviews
Title:Epidemiology and Pathology of Malignant Mesothelioma
Volume: 12 Issue: 4
Author(s): Jack A. Kastelik, Mahmoud Loubani, Michael Greenstone, Simon Hart and Anne Campbell
Affiliation:
Keywords: Asbestos, epidemiology, malignant mesothelioma, pathology.
Abstract: Malignant Mesothelioma: Asbestos are naturally occurring fibrous silicate materials. It is well recognised that inhalation of asbestos fibres especially amphiboles is the most important risk factor for developing mesothelioma. The epidemiological models of association between the risks of asbestos and malignant mesothelioma take into consideration not only cumulative exposure but also time since first exposure. Current epidemiological estimates suggest that mesothelioma will remain a public health problem for a number of years with epidemiological studies suggesting that the peak incidence of mesothelioma has not been reached. In the global context, mesothelioma remains responsible for between 15,000 - 20,000 deaths annually. Malignant mesothelioma can be divided as per World Health Organization classification into epithelioid, sarcomatoid, desmoplastic and biphasic subtypes.
Export Options
About this article
Cite this article as:
Kastelik A. Jack, Loubani Mahmoud, Greenstone Michael, Hart Simon and Campbell Anne, Epidemiology and Pathology of Malignant Mesothelioma, Current Respiratory Medicine Reviews 2016; 12 (4) . https://dx.doi.org/10.2174/1573398X12666160817145726
DOI https://dx.doi.org/10.2174/1573398X12666160817145726 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Metallothioneins and Cancer
Current Protein & Peptide Science MicroRNA: Biogenesis, Function and Role in Cancer
Current Genomics Targeting Prostate Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Drug Repurposing Screen Identifies Novel Classes of Drugs with Anticancer Activity in Mantle Cell Lymphoma
Combinatorial Chemistry & High Throughput Screening Melatonin Regulates Angiogenic and Inflammatory Proteins in MDA-MB-231 Cell Line and in Co-culture with Cancer-associated Fibroblasts
Anti-Cancer Agents in Medicinal Chemistry Subject Index to Volume 4
Current Medicinal Chemistry - Anti-Cancer Agents Functional Role of Glycosphingolipids in Cancer
Current Medicinal Chemistry Malignant Mesothelioma: Cell Survival Pathways and Radiation Therapy
Current Respiratory Medicine Reviews Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic
Current Medicinal Chemistry - Anti-Cancer Agents Targeted – Therapy and Imaging Response: A New Paradigm For Clinical Evaluation?
Reviews on Recent Clinical Trials Recent Clinical Experience with Oncolytic Viruses
Current Pharmaceutical Biotechnology Nicotine, Lung and Cancer
Anti-Cancer Agents in Medicinal Chemistry Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Hypoxia and Inflammation in Prostate Cancer Progression. Cross-talk with Androgen and Estrogen Receptors and Cancer Stem Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Aurora B Kinase and Passenger Proteins as Targets for Cancer Therapy
Current Enzyme Inhibition Going 3D – Cell Culture Approaches for Stem Cell Research and Therapy
Current Tissue Engineering (Discontinued) Sch-66336 (Sarasar®) and Other Benzocycloheptapyridyl Farnesyl Protein Transferase Inhibitors: Discovery, Biology and Clinical Observations
Current Topics in Medicinal Chemistry Neuronal Semaphorins Regulate a Primary Immune Response
Current Neurovascular Research Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
Current Cancer Drug Targets Hypericin - A New Antiviral and Antitumor Photosensitizer: Mechanism of Action and Interaction with Biological Macromolecules
Current Drug Targets